Results 11 to 20 of about 167,047 (315)

Saikosaponin D reverses epinephrine- and norepinephrine-induced gemcitabine resistance in intrahepatic cholangiocarcinoma by downregulating ADRB2/glycolysis signaling

Acta Biochimica et Biophysica Sinica, 2023
Intrahepatic cholangiocarcinoma (iCCA) is a highly fatal malignancy with rapidly increasing incidence and mortality worldwide. Currently, gemcitabine-based systemic chemotherapy is the main clinical therapeutic
He Hui, Guo Jiaqi, Hu Yunxiang, Zhang Han, Li Xinyang, Zhang Jian, Jin Shi   +6 more
doaj   +1 more source

Pediatric Female with Adult Type Small Intestine Gastrointestinal Stromal Tumor [GIST]: A case report [PDF]

International Journal of Medical Arts, 2020
Background: Gastrointestinal stromal tumor [GIST] is commonest mesenchymal tumor, mainly affects adults. But, 1.5% to 2% GISTs were reported in pediatrics and adolescents.
Abdulmohsen Alsuwaigh
doaj   +1 more source

Endoscopic versus laparoscopic treatment for choledocholithiasis: a prospective randomized controlled trial

Endoscopy International Open, 2016
Background and study aims: Overall, 5 % to 15 % of patients undergoing cholecystectomy for cholelithiasis have concomitant bile duct stones, and the incidence of choledocholithiasis increases with age.
Javier Ernesto Barreras González, Rafael Torres Peña, Julián Ruiz Torres, Miguel Ángel Martínez Alfonso, Raúl Brizuela Quintanilla, Maricela Morera Pérez   +5 more
doaj   +1 more source

Renovascular Mistaken as Essential Hypertension due to Giant Hepatic Hydatid: A Rare Treatable Entity

Case Reports in Medicine, 2018
Renovascular hypertension is an unusual but treatable cause of refractory hypertension that is infrequently caused by external compression of the renal vasculature by a giant hydatid cyst, a parasitic infection, caused by Echinococcus granulosus in its ...
Awaji Qasim Alnami, Liaqat Ali Khan, Said Samir Qeshta, Abdulrahman Alnami, Akram Awad, Waleed Mohalwi, Musa Tumaihi   +6 more
doaj   +1 more source

A Comparison of Endoscopic Closure and Laparoscopic Repair for Gastric Wall Defection

Gastroenterology Research and Practice, 2022
Objective. To compare the effectiveness and safety of endoscopic closure and laparoscopic repair for gastric wall defection. Method. The clinical data of 120 patients with submucosal tumours enrolled at our hospital between January 2014 and December 2019
Qiao Qiao, Huiming Tu, Bojian Fei, Kebin Xu, Fan Yang, Jie Li, Qizhong Gao   +6 more
doaj   +1 more source

Suprapubic single-incision laparoscopic right colectomy with complete mesocolic excision, lateral-to-medial approach and intracorporeal anastomoses

International Journal of Gastrointestinal Intervention, 2019
Background : Single-incision laparoscopic right colectomy (SILRC) has been reported in 2008, and since that time an increased number of reports appeared in literature. Currently, it remains popular between the centers with achieved experience.
Giovanni Dapri, Kelly Ann Bobb, Ernesto Jesús Barzola Navarro, Angel Arabadzhiev   +3 more
doaj   +1 more source

The life expectancy of patients with metabolic syndrome after weight loss: study protocol for a randomized clinical trial (LIFEXPE-RT)

Trials, 2019
Background To date, surgeons and physicians have found positive results treating metabolic syndrome with surgical and non-surgical weight loss therapies.
Oral Ospanov, Galymzhan Yeleuov, Irina Kadyrova, Farida Bekmurzinova   +3 more
doaj   +1 more source

Short-Term Results of Sclerotherapy with 3% Polidocanol Foam for Symptomatic Second- and Third-Degree Hemorrhoidal Disease

Journal of Investigative Surgery, 2021
Background Hemorrhoidal disease (HD) is defined as the symptomatic enlargement and/or distal displacement of anal cushions and is one of the most common proctological diseases.
Pierluigi Lobascio, Rita Laforgia, Eugenio Novelli, Fabrizio Perrone, Maria Di Salvo, Angela Pezzolla, Mario Trompetto, Gaetano Gallo   +7 more
doaj   +1 more source

Correction to: The life expectancy of patients with metabolic syndrome after weight loss: study protocol for a randomized clinical trial (LIFEXPE-RT)

Trials, 2019
Following publication of the original article [1], the authors notified us of a typing error in spelling Dr. Yeleuov’s name. The original publication has been corrected.
Oral Ospanov, Galymzhan Yeleuov, Irina Kadyrova, Farida Bekmurzinova   +3 more
doaj   +1 more source

UBQLN1 mediates sorafenib resistance through regulating mitochondrial biogenesis and ROS homeostasis by targeting PGC1β in hepatocellular carcinoma

Signal Transduction and Targeted Therapy, 2021
The treatment for hepatocellular carcinoma (HCC) is promising in recent years, but still facing critical challenges. The first targeted therapy, sorafenib, prolonged the overall survival by months.
Junjie Xu, Lin Ji, Yeling Ruan, Zhe Wan, Zhongjie Lin, Shunjie Xia, Liye Tao, Junhao Zheng, Liuxin Cai, Yifan Wang, Xiao Liang, Xiujun Cai   +11 more
doaj   +1 more source